|
Apr 22
|
How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?
|
|
Apr 22
|
10 Best Performing Biotech ETFs in 2024
|
|
Apr 19
|
Health Canada Approves KEYTRUDA® as a first-line treatment for adult patients with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma in combination with fluoropyrimidine- and platinum-co...
|
|
Apr 18
|
13 Best Low Volatility Stocks to Buy According to Hedge Funds
|
|
Apr 17
|
Coming FDA Approvals Could Send These 3 Drug Stocks Soaring
|
|
Apr 17
|
Merck Insiders Sold US$15m Of Shares Suggesting Hesitancy
|
|
Apr 16
|
3 Dow Stocks to Buy Now: Q2 Edition
|
|
Apr 15
|
10 Best Low Volatility ETFs To Buy
|
|
Apr 12
|
7 A-Rated Aggressive Biotech Stocks to Bet On in 2024
|
|
Apr 11
|
Merck & Co., Inc.'s (NYSE:MRK) Stock Financial Prospects Look Bleak: Should Shareholders Be Prepared For A Share Price Correction?
|
|
Apr 10
|
Moderna (MRNA) Up 6% on Upbeat Data From Cancer Jab Study
|
|
Apr 10
|
Company News for Apr 10, 2024
|
|
Apr 8
|
Golden Years Gainers: 3 Stocks to Fund Your Dream Retirement
|
|
Apr 7
|
The 3 Most Undervalued S&P 500 Stocks to Buy in April 2024
|
|
Apr 7
|
10 Best Weight Loss Drug Stocks to Buy Now
|
|
Apr 6
|
The three-year decline in earnings for Merck NYSE:MRK) isn't encouraging, but shareholders are still up 93% over that period
|
|
Apr 5
|
Merck (MRK) Rises Yet Lags Behind Market: Some Facts Worth Knowing
|
|
Apr 4
|
Merck puts KRAS cancer drug competitor to the test
|
|
Apr 4
|
Merck Initiates Phase 3 Clinical Trial of MK-1084, an Investigational Oral KRAS G12C Inhibitor, in Combination with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Certain Patients With Metastatic Non-Small Cell Lung Cancer
|
|
Apr 3
|
Merck (MRK) Stock Sinks As Market Gains: What You Should Know
|